Recent Updates
Recently added Catalysts
ETON Positive Sentiment Score: 70/100

Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

Monday, April 29, 2024 2 min read
Key Takeaway: Eton Pharmaceuticals has announced that it will report its first quarter 2024 financial results on May 9, 2024. Management will host a conference call at 4:30 p.m. ET to discuss the results and answer questions from investors. Eton continues to focus on developing and commercializing treatments for rare diseases, with several products in both commercial use and late-stage development. Details for accessing the live webcast and registration for the conference call have been provided in the announcement.

Market Sentiment Analysis

POSITIVE FACTORS

  • Eton Pharmaceuticals is preparing to report its financial results, indicating continuous business operations.
  • The company is involved in the development of treatments for rare diseases, a growing and important sector.
  • Positive engagement with investors through live questions and email questions shows transparency.

Full Press Release Details

DEER PARK, Ill., April 29, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton” or the "Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report first quarter 2024 financial results on Thursday, May 9, 2024. Management will host a conference call and live audio webcast to discuss the results at 4:30 p.m. ET (3:30 p.m. CT).
In addition to taking live questions from participants on the conference call, management will be answering emailed questions from investors. Investors can email questions to: investorrelations@etonpharma.com.
The live webcast can be accessed on the Investors section of Eton’s website at https://ir.etonpharma.com/. An archived webcast will be available on Eton’s website approximately two hours after the completion of the event and for 30 days thereafter.
*Conference call participants should register to obtain their dial-in and passcode details. Please be sure to register using a valid email address.
About Eton Pharmaceuticals
Eton is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company currently has five commercial rare disease products: ALKINDI SPRINKLE®, PKU GOLIKE®, Carglumic Acid, Betaine Anhydrous, and Nitisinone. The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO® hydrocortisone autoinjector. For more information, please visit our website at www.etonpharma.com.
In-Site Communications, Inc.
E: lwilson@insitecony.com
Source: Eton Pharmaceuticals

Frequently Asked Questions

When will Eton Pharmaceuticals report Q1 2024 results?

Eton Pharmaceuticals will report first quarter 2024 results on May 9, 2024.

How can investors ask questions during the conference call?

Investors can ask questions during the call or email them to investorrelations@etonpharma.com.

What time is the conference call scheduled?

The conference call is set for 4:30 p.m. ET on May 9, 2024.

Where can I access the live webcast?

The live webcast can be accessed on the Investors section of Eton’s website.

What products does Eton Pharmaceuticals offer?

Eton offers five commercial products for rare diseases and has three candidates in development.

Tags: ETON Viatris Investor Conferences Healthcare Eton Pharmaceuticals rare diseases financial results ET-400 ET-600
Last updated: Apr 29, 2024